TOUL is a device that removes 99.9% of airborne bacteria and micro-organisms, including Coronavirus Covid-19.
According to the European Center for Disease Prevention (ECDC – 2017 Report), Italy is the Country more affected by infections caused by antibiotic-resistant bacteria.
ECDC – Report 2017
Over 90% of bacteria in a patient’s wound come directly or indirectly from air. 30% of them reaches the wound directly from the air, while 70% comes from surgical instruments1. A high bacterial count can be found on the surgical instruments used during surgery as early as 60 minutes after its start2. Colony-forming units (CFU) grow along with the exposure time, the number of people present in the operating room and the number of times the doors are opened.
In a standard operating theatre, instruments are almost always prepared outside the sterile area, because the air vents are not sufficient to cover the entire table. This way, surgical instruments lose their asepsis even before being used.
Would you be willing to open a prosthetic before the surgery even starts? Many people would say no, a prosthetic should be opened at the last minute. And the instruments you are inserting it with, how long have they been opened?
The device creates an ultraclean laminar air flow that reduces the bacterial count on the surgical site and/or instrument table up to 95%, regardless from the surgery duration or quantity of people present in the operating theatre.
TOUL focused laminar flow is direct, and it reaches the instruments and/or the operating field without obstacles, such as shadowless lamps or the surgeons’ heads.
The system is equipped with traceability for defensive medicine: barcode and label on the cover sterile housing can prove that a device compliant with Standard ISO5 has been used, at any time.
Between 2004 and 2018, there’s been an annual increase of infection-related claims of +4.3%.
The operating unit more subject to infection claims is Orthopaedics & Traumatology, with 20.28%.
Most claims come from the surgical area, with 51%.
The average cost of infection claims is 98,831 euro.
The cost of the TOUL system is broadly offset even after a single prevented infection.
With TOUL, you can transform a standard cleanroom into an ISO 5 cleanroom. A required upgrade, since, according to Standard UNI 11425 2011, ISO Class 5 cleanrooms are mandatory for specialized surgeries, such as: organ transplants, implants, neurosurgery and oncologic surgeries, and other complex surgeries lasting longer than 60 minutes and that require an extremely high level of protection of the high-risk area (operating table, instrument table and surgeons operating space).
TOUL is compliant with the strict Standard ISO 5 and ensures that the instruments and operating fields are kept sterile even during very long surgeries, without any time restraints.
The two TOUL Operio and SteriStay mobile units have been used for the past 3 years at the Drammen Hospital, Norway. Employed to complement the standard structural ventilation system, their purpose is reducing the quantity of airborne bacteria known to be a risk factor for open wounds and sterile instruments.
Before using TOUL, the infection risk was 1.5-2% – a common infection rate, as reported in Scandinavian databases.
Infection statistics on 5,000 surgeries show that, for knee and hip replacement surgeries, the risk of deep infections has been reduced to 0.27%.
This data conclusion supports the idea that air sanitization is essential to prevent deep infections, especially in those procedures known to be subject to them.
Many companies that produce osteosynthesis devices, still provide implant materials in boxes, and not in sterile packaging.
In complex traumatology surgery, it is possible that plates and screws are opened at the beginning of the procedure, while preparing the instruments, and kept without protection until the end of the surgery.
A pointlessly dangerous exposure that may last even several hours.
removal of fixation devices
carpal tunnel in outpatient settings
hand surgery in outpatient settings
foot surgery in outpatient settings
PRP and growth factors in outpatient settings